Preoxygenation Optimisation in Obese Patients

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 21, 2017

Primary Completion Date

April 12, 2018

Study Completion Date

April 12, 2018

Conditions
Severe Obesity Design as BMI > 35kg/m2
Interventions
DEVICE

High flow oxygen therapy by nasal cannula. Optiflow®

Patients randomized in interventional group will received a four minutes preoxygenation period with High Flow nasal cannula (60 l/mn FiO2 = 1) before orotracheal intubation. The device will be maintained in place throughout the intubation procedure in order to achieve apnoeic oxygenation.

DEVICE

Facial mask oxygenation in BIPAP ventilation

Patients randomized in BIPAP group will receive a four minutes preoxygenation with EPAP 5, IPAP 15 FiO2 = 1 for a pressure support of 10 cm H2O. The facial mask with be removed after before crash induction enabling laryngoscopic vision

Trial Locations (1)

44093

Nantes University Hospital, Hôtel Dieu, Medical intensive care unit, Nantes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT03106441 - Preoxygenation Optimisation in Obese Patients | Biotech Hunter | Biotech Hunter